Improved cardiac function in a patient with hypereosinophilic syndrome treated with imatinib
Authors:
- 8 June 2005
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 75 (1) , 87-88
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophiliaBlood, 2004
- Imatinib targets other than bcr/abl and their clinical relevance in myeloid disordersBlood, 2004
- Recent advances in pathogenesis and management of hypereosinophilic syndromesAllergy, 2004
- The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and managementBlood, 2004
- Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndromeBlood, 2003
- A Tyrosine Kinase Created by Fusion of thePDGFRAandFIP1L1Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic SyndromeNew England Journal of Medicine, 2003
- Treatment of hypereosinophilic syndrome with imatinib mesilateThe Lancet, 2002